MedTrace Logo

Evaluating the Efficacy of Intranasal Oxytocin Among Individuals With Persistent Pain

NCT02888574 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2022-05-18

No results posted yet for this study

Summary

This study is a placebo-controlled, double-blind, within-participants crossover investigation of the effect of intranasal oxytocin on pain and function among women with chronic pelvic pain.

Conditions

Interventions

DRUG

Intranasal Oxytocin

Intranasal oxytocin (Syntocinon; Novartis, Switzerland)

DRUG

Placebo

Placebo nasal spray

Sponsors & Collaborators

  • University of Calgary

    lead OTHER

Principal Investigators

  • Tavis S Campbell, PhD · University of Calgary

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02888574 on ClinicalTrials.gov